Australia markets open in 4 hours 25 minutes

IQVIA Holdings Inc. (IQV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
192.19+2.32 (+1.22%)
As of 02:35PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close189.87
Bid191.76 x 1300
Ask191.94 x 1300
Day's range190.92 - 193.46
52-week range165.75 - 254.94
Avg. volume973,835
Market cap35.774B
Beta (5Y monthly)1.41
PE ratio (TTM)33.42
EPS (TTM)5.75
Earnings date25 Apr 2023 - 01 May 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est257.58
  • Motley Fool

    2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch

    According to the National Center for Advancing Translational Sciences, the average period from therapy discovery to Food and Drug Administration (FDA) approval is 14 years and costs $1 billion. Clinical research organizations (CROs) and contract development and manufacturing organizations (CDMOs) are growing because the increasing price of developing, testing, manufacturing, and marketing therapies has made it more important that pharmaceutical companies speed the process along with fewer failures. Rather than doing all the clinical trial work or manufacturing work in-house, more healthcare companies are turning to CROs and CDMOs to reduce overhead and expedite bringing therapies to market.

  • Business Wire

    Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute

    RESEARCH TRIANGLE PARK, N.C., March 14, 2023--In 2022, global clinical trial activity remained resilient even as the COVID-19 pandemic stretched through the year, with a 1% decline in non-COVID trial activity compared to 2021. COVID-19 trials as a percentage of total trial activity dropped from 10% to 6% of the 5,756 total trials run in 2022. Non-COVID trial activity increased by 8% between 2019 and 2022, suggesting a restoration to pre-pandemic growth rates, according to a new report, Global Tr

  • Simply Wall St.

    IQVIA Holdings (NYSE:IQV) sheds 10% this week, as yearly returns fall more in line with earnings growth

    IQVIA Holdings Inc. ( NYSE:IQV ) shareholders might be concerned after seeing the share price drop 11% in the last...